Human endometrial stem cells as a new source for programming to neural cells

Area of Science:

• Stem cell biology
• Neuroscience
• Regenerative medicine

Background:

• Human endometrial-derived stem cells (EnSC) are an abundant and accessible source for cell replacement therapy.
• Previous studies demonstrate EnSC's potential to differentiate into mesodermal lineages like osteocytes and adipocytes.

Purpose of the Study:

• To investigate the potential of EnSC for neural differentiation.
• To characterize EnSC and assess their response to neural induction protocols.

Main Methods:

• Flow cytometry was used to characterize EnSC surface markers (CD90, CD105, OCT4, CD44, CD31, CD34, CD133).
• EnSC were induced towards neural differentiation using sequential signaling molecules: basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), and epidermal growth factor (EGF).
• Neural marker expression (Nestin, GABA, MAP2, β3-tubulin, NF-L) was analyzed at mRNA and protein levels using RT-PCR and immunocytochemistry.

Main Results:

• EnSC expressed characteristic stem cell markers and lacked hematopoietic and endothelial markers.
• Following induction, EnSC expressed neural markers at the mRNA level.
• Key neuronal proteins, including MAP2, β3-tubulin, and NF-L, were confirmed in differentiated EnSC 28 days post-treatment.

Conclusions:

• EnSC can be successfully directed towards neuronal differentiation in response to standard neural induction signaling molecules.
• These findings highlight the potential of EnSC as a valuable and unique cell source for therapeutic applications in neurodegenerative diseases.